Sections
| Title | Starting Page | Number of Pages |
|---|
| Cover Page | 1 | 1 |
| List of Contents and Tables | 2 | 1 |
| PROSPECTS and OPPORTUNITIES | 2 | 1 |
| Table/Chart: CATEGORY DATA | 2 | 1 |
| Table/Chart: Tabular Data Analysis | 2 | 1 |
| DERMATOLOGICALS IN GUATEMALA | 3 | 1 |
| Dermatologicals in Guatemala - Category Analysis | 4 | 1 |
| KEY DATA FINDINGS | 4 | 1 |
| 2025 DEVELOPMENTS | 4 | 1 |
| Healthy value growth, partly due to continuing price rises | 4 | 1 |
| Pharmacies continue to dominate distribution | 4 | 1 |
| PROSPECTS and OPPORTUNITIES | 4 | 1 |
| DERMATOLOGICALS IN GUATEMALA | 5 | 1 |
| Muted constant value growth over forecast period | 5 | 1 |
| Guatemala strengthens its role as a regional hub for generic pharma innovation and distribution | 5 | 1 |
| Consumers seek out more natural ingredients in dermatologicals | 5 | 1 |
| CATEGORY DATA | 5 | 1 |
| Table/Chart: GTQ million | 5 | 1 |
| Table/Chart: Tabular Data Analysis | 5 | 1 |
| DERMATOLOGICALS IN GUATEMALA | 6 | 1 |
| Table 2 Sales of Dermatologicals by Category: % Value Growth 2020-2025 | 6 | 1 |
| Table/Chart: Tabular Data Analysis | 6 | 1 |
| Table/Chart: % current value growth | 6 | 1 |
| Table/Chart: Table 3 NBO Company Shares of Dermatologicals: % Value 2021-2025 | 6 | 1 |
| DERMATOLOGICALS IN GUATEMALA | 7 | 1 |
| Table/Chart: Tabular Data Analysis | 7 | 1 |
| Table/Chart: Table 4 LBN Brand Shares of Dermatologicals: % Value 2022-2025 | 7 | 1 |
| DERMATOLOGICALS IN GUATEMALA | 8 | 1 |
| Table 5 Forecast Sales of Dermatologicals by Category: Value 2025-2030 | 8 | 1 |
| Table 6 Forecast Sales of Dermatologicals by Category: % Value Growth 2025-2030 | 8 | 1 |
| Table/Chart: Tabular Data Analysis | 8 | 1 |
| Table/Chart: GTQ million | 8 | 1 |
| Table/Chart: % constant value growth | 8 | 1 |
| DERMATOLOGICALS IN GUATEMALA | 9 | 1 |
| Graph - Note: 2025 data is provisional and based on part-year estimates | 9 | 1 |
| Consumer Health in Guatemala - Industry Overview | 10 | 1 |
| EXECUTIVE SUMMARY | 10 | 1 |
| Key trends in 2025 | 10 | 1 |
| Competitive landscape | 10 | 1 |
| DERMATOLOGICALS IN GUATEMALA | 11 | 1 |
| Channel developments | 11 | 1 |
| What next for consumer health? | 11 | 1 |
| MARKET INDICATORS | 11 | 1 |
| DERMATOLOGICALS IN GUATEMALA | 12 | 1 |
| MARKET DATA | 12 | 1 |
| Table 10 Sales of Consumer Health by Category: % Value Growth 2020-2025 | 12 | 1 |
| Table/Chart: Tabular Data Analysis | 12 | 1 |
| Table/Chart: Table 8 Life Expectancy at Birth 2020-2025 | 12 | 1 |
| Table/Chart: GTQ million | 12 | 1 |
| Table/Chart: % current value growth | 12 | 1 |
| DERMATOLOGICALS IN GUATEMALA | 13 | 1 |
| Table/Chart: Tabular Data Analysis | 13 | 1 |
| Table/Chart: Table 11 NBO Company Shares of Consumer Health: % Value 2021-2025 | 13 | 1 |
| DERMATOLOGICALS IN GUATEMALA | 14 | 1 |
| Table/Chart: Table 12 LBN Brand Shares of Consumer Health: % Value 2022-2025 | 14 | 1 |
| Table/Chart: Tabular Data Analysis | 14 | 1 |
| DERMATOLOGICALS IN GUATEMALA | 15 | 1 |
| Table 13 Penetration of Private Label by Category: % Value 2020-2025 | 15 | 1 |
| Table 14 Distribution of Consumer Health by Format: % Value 2020-2025 | 15 | 1 |
| Table/Chart: % retail value rsp | 15 | 1 |
| Table/Chart: Tabular Data Analysis | 15 | 1 |
| DERMATOLOGICALS IN GUATEMALA | 16 | 1 |
| Table/Chart: Tabular Data Analysis | 16 | 1 |
| Table/Chart: Table 15 Distribution of Consumer Health by Format and Category: % Value 2025 | 16 | 1 |
| DERMATOLOGICALS IN GUATEMALA | 17 | 1 |
| Table/Chart: Tabular Data Analysis | 17 | 1 |
| Table/Chart: Table 16 Forecast Sales of Consumer Health by Category: Value 2025-2030 | 17 | 1 |
| DERMATOLOGICALS IN GUATEMALA | 18 | 1 |
| Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2025-2030 | 18 | 1 |
| APPENDIX | 18 | 1 |
| Otc registration and classification | 18 | 1 |
| Table/Chart: % constant value growth | 18 | 1 |
| Table/Chart: Tabular Data Analysis | 18 | 1 |
| DERMATOLOGICALS IN GUATEMALA | 19 | 1 |
| Vitamins and dietary supplements registration and classification | 19 | 1 |
| Disclosure | 20 | 1 |
| Disclosure | 21 | 1 |
| Graph - Source: Euromonitor International | 21 | 1 |
| Table/Chart: Summary 1 Research Sources | 21 | 1 |
| Table/Chart: Tabular Data Analysis | 21 | 1 |
